1. Soluble Platelet Glycoprotein V Is a Marker of Thrombosis in Patients With Ischemic Stroke
by Valérie Wolff, Boris Aleil, Maurice Giroud, Jean-Louis Lorenzini, Nicolas Meyer, Marie-Louise Wiesel, Jean-Pierre Cazenave, and François Lanza
Stroke
Volume 36(3):E17-E19
March 1, 2005
Copyright © American Heart Association, Inc. All rights reserved.

2. Effects of antithrombotic treatment on plasma levels of sGPV in patients with ischemic stroke.
Effects of antithrombotic treatment on plasma levels of sGPV in patients with ischemic stroke. Antiplatelet treatment, Aspirin or clopidogrel; ineffective anticoagulant treatment with warfarin or unfractionated heparin, INR or aPTT ratio <2; effective anticoagulant treatment, INR or aPTT ratio 2 to 3 (Kruskall–Wallis test).
Valérie Wolff et al. Stroke. 2005;36:E17-E19
Copyright © American Heart Association, Inc. All rights reserved.